Greg Zante - Oct 28, 2024 Form 4 Insider Report for Viking Therapeutics, Inc. (VKTX)

Signature
/s/ Michael Morneau as Attorney-in-Fact
Stock symbol
VKTX
Transactions as of
Oct 28, 2024
Transactions value $
-$9,384,882
Form type
4
Date filed
10/28/2024, 09:48 PM
Previous filing
Jul 31, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VKTX Common Stock, par value $0.00001 per share Options Exercise $99.1K +12.8K +6.82% $7.77 200K Oct 28, 2024 Direct F1
transaction VKTX Common Stock, par value $0.00001 per share Options Exercise $19.9K +4.25K +2.13% $4.68 204K Oct 28, 2024 Direct F1
transaction VKTX Common Stock, par value $0.00001 per share Options Exercise $151K +26K +12.74% $5.80 230K Oct 28, 2024 Direct F1
transaction VKTX Common Stock, par value $0.00001 per share Options Exercise $435K +51K +22.17% $8.52 281K Oct 28, 2024 Direct F1
transaction VKTX Common Stock, par value $0.00001 per share Sale -$3.7M -49.7K -17.67% $74.56 231K Oct 28, 2024 Direct F1, F2
transaction VKTX Common Stock, par value $0.00001 per share Sale -$1.41M -18.6K -8.05% $75.79 213K Oct 28, 2024 Direct F1, F3
transaction VKTX Common Stock, par value $0.00001 per share Sale -$713K -9.27K -4.35% $76.94 203K Oct 28, 2024 Direct F1, F4
transaction VKTX Common Stock, par value $0.00001 per share Sale -$1.79M -23.1K -11.34% $77.68 180K Oct 28, 2024 Direct F1, F5
transaction VKTX Common Stock, par value $0.00001 per share Sale -$1.25M -15.8K -8.77% $78.69 165K Oct 28, 2024 Direct F1, F6
transaction VKTX Common Stock, par value $0.00001 per share Sale -$483K -6.05K -3.68% $79.78 159K Oct 28, 2024 Direct F1, F7
transaction VKTX Common Stock, par value $0.00001 per share Sale -$643K -7.97K -5.03% $80.65 151K Oct 28, 2024 Direct F1, F8
transaction VKTX Common Stock, par value $0.00001 per share Sale -$98.2K -1.21K -0.8% $81.44 149K Oct 28, 2024 Direct F1, F9

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VKTX Stock Option (Right to Buy) Options Exercise $0 -12.8K -100% $0.00 0 Oct 28, 2024 Common Stock 12.8K $7.77 Direct F1, F10
transaction VKTX Stock Option (Right to Buy) Options Exercise $0 -4.25K -100% $0.00 0 Oct 28, 2024 Common Stock 4.25K $4.68 Direct F1, F10
transaction VKTX Stock Option (Right to Buy) Options Exercise $0 -26K -100% $0.00 0 Oct 28, 2024 Common Stock 26K $5.80 Direct F1, F11
transaction VKTX Stock Option (Right to Buy) Options Exercise $0 -51K -25% $0.00 153K Oct 28, 2024 Common Stock 51K $8.52 Direct F1, F12
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted on July 29, 2024 by the Reporting Person.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $74.24 to $75.23, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.24 to $76.23, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.27 to $77.26, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.27 to $78.26, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.27 to $79.26, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.29 to $80.28, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.30 to $81.27, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.35 to $81.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F10 25% of the shares subject to the option vested on each anniversary of the grant date.
F11 One-third of the shares subject to the option vested on each anniversary of the grant date.
F12 25% of the shares subject to the option vested or will vest on each anniversary of the grant date.